Form 4: Elanco Animal Health CEO Jeffrey Simmons Acquires Deferred Stock Units
SEC Form 4 Filing
Elanco Animal Health's CEO, Jeffrey N. Simmons, acquired deferred stock units representing the right to receive common stock or cash equivalent, according to a recent SEC filing.
Summary
- On March 7, 2025, Jeffrey N. Simmons, the President, CEO, and Director of Elanco Animal Health Inc., acquired 8,902.8043 deferred stock units.
- These deferred stock units represent the right to receive one share of Elanco's common stock or the cash equivalent.
- The acquisition price for the deferred stock units was $11.14.
- Following the transaction, Simmons directly owns 14,858.5356 deferred stock units.
- The deferred stock units will settle in cash or shares of Elanco common stock following termination of employment or during a specified future year, as per the Executive Deferral and Stock Match Plan.
Sentiment
Score: 7
Explanation: The sentiment is neutral to slightly positive. It reflects a standard executive compensation transaction, indicating confidence from the CEO in the company's future.
Positives
- The acquisition of deferred stock units by the CEO demonstrates confidence in the company's future performance.
Future Outlook
The deferred stock units will settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan.
Industry Context
Executive compensation through deferred stock units is a common practice in publicly traded companies to align management's interests with those of shareholders.
Comparison to Industry Standards
- Deferred stock units are a typical component of executive compensation packages in the pharmaceutical and animal health industries.
- Companies like Zoetis and Merck Animal Health also utilize similar equity-based compensation plans for their executives.
Stakeholder Impact
- The acquisition of deferred stock units by the CEO aligns his interests with those of the shareholders, potentially driving long-term value creation.
Key Dates
| Date | Description |
|---|---|
| 03/07/2025 | Date of transaction: Jeffrey N. Simmons acquired deferred stock units. |
| 03/11/2025 | Date of signature on the SEC filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.